Literature DB >> 31144756

Phenotyping of interstitial cystitis/bladder pain syndrome.

Yoshiyuki Akiyama1, Philip Hanno2.   

Abstract

Interstitial cystitis/bladder pain syndrome is a chronic, potentially debilitating condition characterized by pain perceived to be related to the bladder in conjunction with lower urinary tract symptoms, and includes a wide variety of clinical phenotypes with diverse etiologies. Currently the only clinically relevant proven phenotype of interstitial cystitis/bladder pain syndrome is the Hunner lesion. Whether the presence of Hunner lesions is a hallmark of a distinct disease cohort or a potentially transient feature of non-Hunner lesion phenotype has been debated but remains controversial. There are few documented examples of a patient converting between the two forms. Growing clinical and basic evidence supports eliminating the Hunner lesion phenotype from the bladder pain syndrome umbrella and considering it a distinct disease. The Hunner lesion phenotype is characterized by distinct bladder histology, including subepithelial chronic inflammatory changes and epithelial denudation, and specific clinical characteristics (older onset age, severe bladder-centric symptoms, reduced bladder capacity, and favorable response to the lesion-targeted therapies). To define the Hunner lesion phenotype, it is necessary to develop an atlas of standardized images of cystoscopic (and, if possible, pathological) appearances of Hunner lesions. A true potential and clinically relevant phenotype of interstitial cystitis/bladder pain syndrome may be patients with non-bladder-centric symptoms, characterized by the affect dysregulation and somatic symptoms, and a greater bladder capacity in absence of Hunner lesions. In the present workshop, we concluded that the Hunner lesion is a valid phenotype and can reasonably be considered a disease in its own right. Assessment of bladder capacity and the extent of symptoms (bladder beyond or bladder centric) may help phenotyping of interstitial cystitis/bladder pain syndrome. Proper phenotyping is essential for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome, and for facilitating research. Editorial material and organization
© 2019 The Japanese Urological Association. Copyright of individual abstracts remains with the authors.

Entities:  

Keywords:  Hunner lesions; IC/BPS; bladder pain syndrome; interstitial cystitis; painful bladder syndrome; phenotyping

Year:  2019        PMID: 31144756     DOI: 10.1111/iju.13969

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  20 in total

1.  [Urodynamic and histological evaluation of cyclophosphamide-induced bladder pain syndrome in SD rats].

Authors:  L Zhu; W Y Zhang; K X Xu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

Review 2.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

3.  Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Authors:  Alyssa Gracely; Anne P Cameron
Journal:  Drugs Aging       Date:  2020-10-23       Impact factor: 3.923

4.  Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis.

Authors:  Yoshiyuki Akiyama; Jian-Rong Yao; Karl J Kreder; Michael A O'Donnell; Susan K Lutgendorf; Dan Lyu; Daichi Maeda; Haruki Kume; Yukio Homma; Yi Luo
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-14

5.  Relationship between the frequency of electrocautery of Hunner lesions and changes in bladder capacity in patients with Hunner type interstitial cystitis.

Authors:  Yoshiyuki Akiyama; Masayoshi Zaitsu; Daiji Watanabe; Itsuki Yoshimura; Aya Niimi; Akira Nomiya; Yuta Yamada; Yusuke Sato; Masaki Nakamura; Taketo Kawai; Daisuke Yamada; Motofumi Suzuki; Haruki Kume; Yukio Homma
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

6.  Unsupervised Machine Learning Approaches Reveal Distinct Phenotypes of Perceived Bladder Pain: A Pilot Study.

Authors:  Patricia J Mwesigwa; Nicholas J Jackson; Ashley T Caron; Falisha Kanji; James E Ackerman; Jessica R Webb; Victoria C S Scott; Karyn S Eilber; David M Underhill; Jennifer T Anger; A Lenore Ackerman
Journal:  Front Pain Res (Lausanne)       Date:  2021-11-05

7.  A nomogram for bladder pain syndrome/interstitial cystitis based on netrin-1.

Authors:  Xiaojie Ang; Yufeng Jiang; Zongqiang Cai; Qi Zhou; Miao Li; Bin Zhang; Weiguo Chen; Li-Hua Chen; Xi Zhang
Journal:  Int Urol Nephrol       Date:  2021-12-13       Impact factor: 2.370

8.  Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis.

Authors:  A Ledda; S Hu; M R Cesarone; G Belcaro; M Dugall; B Feragalli; R Cotellese; M Hosoi; E Ippolito; M Corsi; R Luzzi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629

Review 9.  Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.

Authors:  Yoshiyuki Akiyama
Journal:  Diagnostics (Basel)       Date:  2021-11-30

Review 10.  MRI as a Tool to Assess Interstitial Cystitis Associated Bladder and Brain Pathologies.

Authors:  Rheal A Towner; Nataliya Smith; Debra Saunders; Robert E Hurst
Journal:  Diagnostics (Basel)       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.